Effects of acute administration of L-arginine on morphine antinociception and morphine distribution in central and peripheral tissues of mice

Pharmacology Biochemistry and Behavior

Volumn 61, Issue 1, 1998, Pages 29-33

  Bhargava, Hemendra N ^a   Bian, Jing Tan ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Antinociception; Brain regions; Morphine; Morphine concentration; Nitric oxide; Peripheral tissues

Indexed keywords

ARGININE; DEXTRO ARGININE; MORPHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, OPIOID; ANIMALS; ARGININE; CENTRAL NERVOUS SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MICE; MORPHINE; NITRIC OXIDE; PERIPHERAL NERVOUS SYSTEM; STEREOISOMERISM; TISSUE DISTRIBUTION;

EID: 0031721881     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00067-7     Document Type: Article

References (12)

1. G-Nitro-L-arginine reverses L-arginine induced decreases in morphine antinociception and regional brain distribution in mice. Brain Res. 749:351-353; 1997.
2. Bhargava, H. N.; Bian, J. T.; Kumar, S.: Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine. J. Pharmacol. Exp. Ther. 281:707-712; 1997.
3. Bhargava, H. N.; Villar, V. M.: Pharmacodynamics and pharmacokinetics of intravenously administered morphine in 8- and 24-week old rats. Pharmacology (Basel) 43:256-262; 1991.
4. Bhargava, H. N.; Villar, V. M.: Tolerance-dependence and serum elimination of morphine in rats implanted with morphine pellets. Gen. Pharmacol. 22:1033-1042; 1991.
5. Bhargava, H. N.; Villar, V. M.; Gulati, A.; Chari, G.: Analgesic and hyperthermic effects of intravenously administered morphine in the rat are related to its serum levels. J. Pharmacol. Exp. Ther. 258:511-516; 1991.
6. Bhargava, H. N.; Villar, V. M.: Pharmacodynamics and pharmacokinetics of intravenously administered morphine in spontaneously hypertensive and normotensive Wistar-Kyoto rats. J. Pharmacol. Exp. Ther. 261:290-296; 1992.
7. Bhargava, H. N.; Villar, V. M.; Rahmani, N. H.; Larsen, A. K.: Time course of the distribution of morphine in brain regions and spinal cord after intravenous injection to spontaneously hypertensive and normotensive Wistar-Kyoto rats. J. Pharmacol. Exp. Ther. 261:1008-1014; 1992.
8. 2-opioid receptor agonists in mice. Brain Res. 719:56-61; 1996.
9. G-nitro-L-arginine or their combination on morphine concentration in peripheral tissues and urine of the mouse. Gen. Pharmacol. 30:753-757; 1998.
10. Brignola, G.; Calignano, A.; Di Rosa, M.: Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br. J. Pharmacol. 113:1372-1376; 1994.
11. D'Amour, F. E.; Smith, D. L.: A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:74-79; 1941.
12. Moncada, S.; Palmer, R. M. J.; Higgs, E. A.: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142; 1991.